chr12-6977182-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005768.6(LPCAT3):​c.1428G>A​(p.Met476Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

LPCAT3
NM_005768.6 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.25
Variant links:
Genes affected
LPCAT3 (HGNC:30244): (lysophosphatidylcholine acyltransferase 3) Enables 1-acylglycerophosphocholine O-acyltransferase activity; 1-acylglycerophosphoethanolamine O-acyltransferase activity; and 1-acylglycerophosphoserine O-acyltransferase activity. Involved in phosphatidylcholine acyl-chain remodeling; phosphatidylethanolamine acyl-chain remodeling; and phosphatidylserine acyl-chain remodeling. Located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
EMG1 (HGNC:16912): (EMG1 N1-specific pseudouridine methyltransferase) This gene encodes an essential, conserved eukaryotic protein that methylates pseudouridine in 18S rRNA. The related protein in yeast is a component of the small subunit processome and is essential for biogenesis of the ribosomal 40S subunit. A mutation in this gene has been associated with Bowen-Conradi syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.085244924).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LPCAT3NM_005768.6 linkuse as main transcriptc.1428G>A p.Met476Ile missense_variant 12/13 ENST00000261407.9 NP_005759.4 Q6P1A2-1
EMG1NM_006331.8 linkuse as main transcriptc.*1373C>T 3_prime_UTR_variant 6/6 ENST00000599672.6 NP_006322.4 Q92979
EMG1NM_001320049.2 linkuse as main transcriptc.*1373C>T 3_prime_UTR_variant 5/5 NP_001306978.1 Q92979
EMG1NR_135131.2 linkuse as main transcriptn.632+1804C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LPCAT3ENST00000261407.9 linkuse as main transcriptc.1428G>A p.Met476Ile missense_variant 12/131 NM_005768.6 ENSP00000261407.4 Q6P1A2-1
EMG1ENST00000599672.6 linkuse as main transcriptc.*1373C>T 3_prime_UTR_variant 6/61 NM_006331.8 ENSP00000470560.1 Q92979
ENSG00000290146ENST00000607161.5 linkuse as main transcriptn.624+1804C>T intron_variant 2 ENSP00000480420.1 A0A087WWQ2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461048
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
726900
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 12, 2024The c.1428G>A (p.M476I) alteration is located in exon 12 (coding exon 12) of the LPCAT3 gene. This alteration results from a G to A substitution at nucleotide position 1428, causing the methionine (M) at amino acid position 476 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.011
T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.085
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.35
N
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.15
N
REVEL
Benign
0.035
Sift
Benign
0.27
T
Sift4G
Benign
0.31
T
Polyphen
0.0
B
Vest4
0.11
MutPred
0.40
Gain of catalytic residue at P478 (P = 0.0274);
MVP
0.093
MPC
0.78
ClinPred
0.24
T
GERP RS
3.9
Varity_R
0.11
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1946413615; hg19: chr12-7086344; API